Brought to you by:
-
Vascular trainees better prepared for open aortic practice than commonly reported, new study shows
Current graduates from both vascular surgery residency and fellowship programs are well prepared for surgical practice in aortic disease whether they are performing open repair or endovascular therapy, contrasting with research indicating that trainees are entering the workforce with inadequate experience of open aortic repair. That is the main finding of a new study set…
-
The endovascular revolution and open aortic training: ‘It’s not necessarily a crisis but it could become one’
Jean Panneton, MD, considers himself what he terms a “blue-collar” vascular surgeon as much as one engaged in academic practice and the necessity of helping contribute to the next generation of vascular surgeons. He operates. And he operates a lot. But he is also a professor of surgery, and a program director in charge of…
-
chronic venous insufficiency, Envveno Medical, VEITH 2024, VEITHsymposium, Venous disease, venous valve, VenoValve
Positive one-year data for new venous valve portends promising future in chronic venous insufficiency treatment
SAVVE trial principal investigators discuss results showing 98.4% VenoValve device patency, 85% clinically meaningful benefit and an 80% rate of ulcer size reduction at 12 months. Fresh from delivering positive one-year data from the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) pivotal trial at the 2024 VEITHsymposium in New York City (Nov. 19–23), site principal investigators…
-
Novel bioabsorbable perivascular wrap aims to reduce AVF failure
Ellen Dillavou, MD, division chief of vascular surgery at WakeMed Heart Center in Raleigh, North Carolina, primary investigator (PI) for the VenoStent trial, presented new data during the 2024 VEITHsymposium in New York City (Nov. 19–23) about the SelfWrap (VenoStent) bioabsorbable perivascular wrap, outlining how the novel device can, she says, improve arteriovenous fistula (AVF)…
-
When RCTs are essential for novel vascular access device regulation
As part of a 2024 VEITHsymposium (New York City; Nov. 19–23) debate, Robert E Lee, MD, a medical officer recently retired from the Food and Drug Administration (FDA), presented an argument in favor of when the use of randomized controlled trials (RCTs) for the regulation and approval of novel vascular access devices becomes important. “Randomization,”…
-
Venous VQI celebrates decade milestone
At the recent VEITHsymposium (Nov. 19–23) in New York City, Marc Passman, MD, reflected on the achievements of the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) venous arm, in collaboration with the American Venous Forum (AVF), since its inception 10 years ago. Passman, who is professor of surgery in the Division of Vascular…
-
In search of the ‘holy grail’: New analysis brings aneurysm rupture prediction closer
A rupture prediction-based algorithm is set to enhance patient selection for abdominal aortic aneurysm (AAA) repair. This is according to Randy Moore, MD, a vascular surgeon at the University of Calgary in Calgary, Canada, who, at the 2024 VEITHsymposium (Nov. 19–23) in New York City reported that the ViTAA system (ViTAA Medical Solutions) can predict…
-
VAM 2025 abstract submission period opens
Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June through Wednesday, Jan. 8, 2025. The submission period opened Nov. 6. VAM research—both clinical and translational—is considered for presentation in several different forums that appeal to all attendees, from plenary presentations, rapid-fire talks, international and video sessions, poster…
-
In focus: Outpatient vascular practice
This month, Vascular Specialist launches its newest column, The Outpatient, which seeks to cover issues near and dear to the hearts of vascular surgeons practicing in outpatient settings such as office-based labs (OBLs) and ambulatory surgery centers (ASCs). Here, in the inaugural edition, Robert Molnar, MD, and Anil Hingorani, MD— two key figures behind the…
-
Applications open for 2025 James S.T. Yao Resident Research Award
The SVS Foundation is accepting applications for the 2025 James S.T. Yao Resident Research Award, which supports emerging medical professionals researching vascular disease biology and innovative translational therapies. The application deadline is Jan. 8, 2025. The recipient will present their research at the 2025 Vascular Annual Meeting (VAM), which takes place in New Orleans (…